Breast cancer can be classified into two major clinically important groups by immunohistochemistry (IHC): human epidermal growth factor receptor 2 (HER2) positive (IHC 3+) and HER2 negative (IHC 0/1+). The gene discussed is ERBB2; the disease is breast cancer.